Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 9, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • cancer
  • Page 4

Tag: cancer

  • BiotechToday
  • World

Database of GENomic Variants of Oral Cancer: dbGENVOC

BioTech Today July 10, 2021July 10, 2021 2

Nandini Pharasi, Jaypee Institute of Information Technology Oral cancer, also known as mouth cancer develops in any part of the mouth due to genetic mutations. The reasons for this could be the usage of tobacco, heavy liquor, or human papillomavirus (HPV) infection. Symptoms include a lump or a red or white patch inside the mouth […]

Read More
  • BiotechToday
  • World

Endometrial Cancer Treatment via Adjuvant Radiotherapy

bioxone July 9, 2021July 9, 2021

Shayan Ahmed, Jamia Millia Islamia, New Delhi Endometrial cancer (EC) is the most prevalent gynaecological cancer, with endometrioid adenocarcinoma accounting for the majority of cases. Surgical intervention is considered to be the most radical type of treatment. Therefore, adjuvant radiotherapy is advised for certain patient subgroups for endometrial cancer treatment. To remove microscopic disease in […]

Read More
  • BiotechToday
  • World

RASSF10 gene’s gastric cancer inhibiting mechanisms revealed!

BioTech Today July 7, 2021July 6, 2021

Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University To grow, cells have to divide. A single cell divides into two, and then four, and so on. Finally, we turn into a body with trillions of cells. Each cell undergoes differentiation to get its specialized function. From this, it might be quite clear how essential cell […]

Read More
  • BiotechToday
  • World

“Death Star” in cancer biology- the mutated form of RAS protein

BioTech Today July 3, 2021July 2, 2021

Sayak Banerjee, Amity University Kolkata The scientists at the University of Leeds have discovered a new method of targeting a mutated protein, which is the reason behind most of the fatal cancers. The mutated form of RAS protein is often considered the “Death Star” since it has the potential to resist various treatments. Although RAS […]

Read More
  • BiotechToday
  • World

Decontamination strategy for detection of cfmDNA in humans

bioxone June 26, 2021June 26, 2021

Madhavi Bhatia, NIPER Guwahati. The gut flora of humans acts as a major factor that influences the health of an individual. The microbiome may affect the disease progression and response to immunotherapy. So, the gut microbiome can act as a cancer biomarker. For analyzing this high throughput 16S-rRNA-gene-based approach is utilized to detect a genuine […]

Read More
  • BiotechToday
  • World

Pancreatic Cancer Stem Cells & Tumorigenesis

bioxone June 26, 2021June 26, 2021 4

Shayan Ahmed, Jamia Millia Islamia, New Delhi Cancer stem cells (CSCs) have recently been discovered in a number of different cancers, including pancreatic cancers. These are called pancreatic cancer stem cells (PCSCs). Pancreatic cancer is a frequently occurring cancer with a bad prognosis. Evidence suggests that sirtuin 1 (SIRT1) has biological activities that contribute to […]

Read More
  • BiotechToday
  • World

CDK9: A Key regulator of RNA Polymerase II Transcription

bioxone June 24, 2021June 23, 2021 1

Shayan Ahmed, Jamia Millia Islamia, New Delhi It has been discovered that Cyclin-Dependent Kinase 9 (CDK9) is an important regulator of RNA Polymerase II transcription. As a regulator CDK9 works across the transcription unit at multiple locations. These include the transcriptional pause release before elongation by the action of positive transcription elongation factor b (P-TEFb). […]

Read More
  • BiotechToday
  • World

Greed for fatty acids become lethal for cancer

BioTech Today June 19, 2021June 19, 2021 2

Ananya Dutta, Bose Institute The contribution of several nutrients to cancer cells’ biosynthetic, bioenergetic, and antioxidant requirements has been intensively researched over the last decade. The connection between cancer genetics and metabolic rewiring, in particular, has resulted in significant findings, opening up new treatment avenues for certain cancer types. Clinicians are interested in how food […]

Read More
  • BiotechToday
  • World

Cancer can be smart, but the immune system is smarter!

bioxone June 11, 2021June 11, 2021

Ananya Dutta, Bose Institute This is the aphorism of Memorial Sloan Kettering (MSK) Cancer Center, New York, USA.  At MSK it is believed that immunotherapy is one of the most promising treatments to treat, cure, and eventually prevent cancer. Immunotherapy cradled from MSK about more than a century ago. William Coley (1893), a surgeon at […]

Read More
  • BiotechToday
  • World

PARP inhibitors: One class of drugs for Multiple Forms of Cancer

bioxone June 10, 2021June 10, 2021 3

Sayak Banerjee, Amity University Kolkata Scientists have come over a class of drugs utilized in the treatment of breast and ovarian cancer which might be effective in other types of diseases with inadequate treatment alternatives. These are called PARP inhibitors which have the potential to kill cancer cells carrying a defect in the Polybromo 1(PBRM1) […]

Read More

Posts navigation

1 2 3 4 5 6 7 8 … 11

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy